LHLieke J. van Heurn

Lieke J. van Heurn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lieke J. van Heurn has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • Eva Pajkrt

    Amsterdam UMC University of Amsterdam & Vrije Universiteit Amsterdam Department of Obstetrics Amsterdam The Netherlands

    2 shared publications
  • Joep P. M. Derikx

    Emma Children's Hospital University of Amsterdam & Vrije Universiteit Amsterdam Department of P(a)ediatric Surgery Amsterdam UMC Amsterdam The Netherlands

    2 shared publications
  • L. W. Ernest van Heurn

    Emma Children's Hospital University of Amsterdam & Vrije Universiteit Amsterdam Department of P(a)ediatric Surgery Amsterdam UMC Amsterdam The Netherlands

    2 shared publications
  • L. W. Ernest van Heurn

    Emma Children's Hospital, Amsterdam UMC, University of Amsterdam & Vrije Universiteit Amsterdam, Department of Pediatric Surgery, Amsterdam, The Netherlands

    2 shared publications
  • Nigel J. Hall

    University Surgery Unit, Faculty of Medicine, University of Southampton, Southampton, UK

    2 shared publications
  • Shawn D. St. Peter

    Department of Surgery, Children's Mercy Hospital, Kansas City, MO 64108, USA

    2 shared publications

Latest Publications

  • Open Access

    Malignant transformation of sacrococcygeal teratoma versus presacral teratoma in Currarino syndrome: Results of ‘The SCT-study’

    by Lieke J van Heurn, Joep P M Derikx, Nigel J Hall, Amr Abdelhamid AbouZeid, Simone de Campos Vieira Abib, Lohfa B Chirdan, Shigehisa Fumino, Seong C Kim, Oliver Muensterer, Maricarmen Olivos, et al.

  • Open Access

    Malignant transformation and tumour recurrence in sacrococcygeal teratoma: a global, retrospective cohort study

    by Lieke J. van Heurn, Joep P.M. Derikx, Nigel Hall, Jennifer H. Aldrink, Maria M. Bailez, Lohfa B. Chirdan, Shigehisa Fumino, Afua Hesse, Tuktu Soyer, Shawn StPeter, et al.

    Introduction: Sacrococcygeal teratoma (SCT) is a rare congenital tumour. The risk of malignancy and recurrence is not well defined. Previous studies are small and report differing conclusions about the timing of surgery and the duration of follow-up. The authors studied the risk of malignant transformation and SCT recurrence after surgery to address these gaps. Methods: This was a global retrospective cohort study. Data of consecutive SCT patients was obtained from 145 institutes in 62 countries. Malignant transformation, defined as malignancy at initial resection, malignant recurrence or death due to malignancy, and its risk factors were analysed. Results: Of the 3612 included patients, 3407 entered analysis. The risk of malignant transformation of the initial tumour was 3.3, 5.1, 10.1, and 32.9% at age 3 months, 6 months, 1 year, and 2 years, respectively. After 6 years, the censored risk of malignancy (64%) did not further increase. Recurrent SCT was diagnosed in 349 (10.2%) children with 126 (36.1%) malignant recurrences. Risk factors for recurrence were Altman type II [odds ratio (OR): 1.6, 95% confidence interval (CI): 1.2–2.2], Altman type III (OR: 1.6, 95% CI: 1.2–2.3), initial immature histology (OR: 1.9, 95% CI: 1.4–2.6), and initial malignant histology (OR: 4.0, 95% CI: 2.9–5.4). Conclusion: The risk of malignancy at initial resection in SCT increases with age reaching a plateau at 6 years of age. Recurrence after resection occurred in 10% of patients and 36% of these were malignant at that time. Altman type II or type III, and immature or malignant histology were associated with recurrence. Level of evidence: Level III.


  • Open Access

    The Diagnostic Accuracy of Serum Alpha-Fetoprotein Levels in Follow-up for Recurrence of Sacrococcygeal Teratoma; a Nationwide Review of SCT Cases in the Netherlands

    by Lieke J. van Heurn, Marijke E.B. Kremer, Ivo de Blaauw, Robertine van Baren, Wim G. van Gemert, Johannes B. van Goudoever, Cornelius E.J. Sloots, Marieke J. Witvliet, L.W. Ernest van Heurn, Joep P.M. Derikx


  • Open Access

    Prognostic accuracy of factors associated with poor outcome in prenatally diagnosed sacrococcygeal teratoma: A systematic review and meta‐analysis

    by Lieke J. van Heurn, Audrey Coumans, Monique C. Haak, Annemarth van der Kaaij, L. W. Ernest van Heurn, Eva Pajkrt, Joep P. M. Derikx

    Several factors associated with poor outcome in patients with prenatally diagnosed sacrococcygeal teratoma (SCT) have been found. However, the prognostic accuracy of these factors has not been well established. Therefore, we aimed to systematically review the prognostic accuracy of factors associated with poor outcome in these patients. We queried Search Premier, COCHRANE Library, EMCARE, EMBASE, PubMed, ScienceDirect, and Web of Science databases to identify studies regarding patients with prenatally diagnosed SCT. Poor outcome was defined as termination of pregnancy (TOP), intrauterine fetal death (IUFD), or perinatal death. We estimated the odds ratio of factors associated with poor outcome. Eleven studies (447 patients) were included. Overall mortality, including TOP, was 34.9%. Factors associated with poor outcome in fetuses with prenatally diagnosed SCT were cardiomegaly, hypervascular tumor, solid tumor morphology, fetal hydrops, and placentomegaly. A tumor volume to fetal weight ratio (TFR) of >0.12 before a gestational age of 24 weeks is predictive of poor outcome. The prognostic accuracy of factors associated with poor outcome in fetuses prenatally diagnosed with SCT seems promising. Factors associated with cardiac failure such as cardiomegaly, hypervascular tumor, solid tumor morphology, fetal hydrops, placentomegaly, and TFR >0.12 were found to be predictive of poor outcome.


  • Open Access

    Factors associated with poor outcome in fetuses prenatally diagnosed with sacrococcygeal teratoma

    by Lieke J. van Heurn, Audrey B. C. Coumans, Joep P. M. Derikx, Mireille N. Bekker, Katia M. Bilardo, Leonie K. Duin, Maarten F. C. M. Knapen, Eva Pajkrt, Esther Sikkel, L. W. Ernest van Heurn, et al.

    Aim of the study: Outcome of fetuses, prenatally diagnosed with sacrococcygeal teratoma (SCT), is still poorly documented. This study assesses the incidence and prenatal predictors of outcome in all fetuses prenatally diagnosed with SCT.Methods: This is a retrospective study on all fetuses prenatally diagnosed with SCT from 1998 to 2018 in the Netherlands. Poor outcome was defined as terminations of pregnancy (TOP) because of expected unfavorable outcome, intrauterine fetal death, or early neonatal death. Potential risk factors for poor outcome were analyzed.Main results: Eighty‐four fetuses were included. Sixteen (19.0%) TOPs were excluded from statistical analysis. Eleven of the remaining 68 fetuses had poor outcome. Overall mortality was 32.1%, with a mortality excluding TOPs of 13.1%. Thirteen fetal interventions were performed in 11 (13.1%) fetuses. Potential risk factors for poor outcome were the presence of fetal hydrops (OR: 21.0, CI: 2.6–275.1, p = 0.012) and cardiomegaly (OR: 10.3, CI: 1.9–55.8, p = 0.011).Conclusions: The overall mortality of fetuses prenatally diagnosed with SCTs including tTOP was 32.1%. This high mortality rate was mainly due to termination of pregnancy. Mortality excluding TOP was 13.1%. Potential risk factors for poor outcome were fetal hydrops and cardiomegaly.